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The liver's role in vinyl chloride toxicity and carcinogenicity is providing a better understanding ofthe
chemical carcinogenesis mechanism. A variety of both malignant and benign hepatic tumors has been
demonstrated with prolonged exposure to vinyl chloride. The multi-system involvment ofthis carcinogen
and toxin has provided a model for the study ofchemical carcinogenesis common to both man and animal.
Clinical studies have shown the usefulness of biochemical, radioisotopic, and radiological studies in the
detection of toxic and carcinogenic lesions. Animal studies have demonstrated the biochemical metab-
olism by the liver ofvinyl chloride-produced intermediates which are mutagenic in bacterial systems and
may be the ultimate carcinogens. Hepatic subcellular enzyme studies prove preliminary evidence of
cellular adaptation and increased detoxification. Disruption ofthis oxidization and detoxification balance
may be the key to the malignant transformation of cells. A working hypothesis is presented which may
explain the metabolism of vinyl chloride into mutagenic intermediates by the liver celi and the develop-
ment ofmalignant transformation by extra hepatic sinusoidal lining cells, lung cells, and brain tissue.
INTRODUCTION
Currently there is a growing concern that chemical compounds may be respon-
sible for most human cancer through environmental contact. Although 100,000 to
200,000 newchemicals are introduced into industry eachyear, little is knownabout
their effects. These compounds are primarily synthetics and thus not natural tothe
environment. The view that industrial chemicals may be latent carcinogenic
hazards has again been brought into sharpfocus by the discovery ofvinyl chloride-
induced angiosarcoma. Vinyl chloride (CH2 = CH-Cl monochloroethyene, agas)
is the basic molecule ormonomerofpolyvinyl chloride and itsco-polymers and one
ofthe most important organic intermediates in the plastics industry. The resulting
plastic resin, polyvinyl chloride, is used in innumerable consumer and industrial
products, such as containers, wrapping film, electrical insulation, pipelines, credit
cards, etc. Until recently (early 1970's) vinyl chloride was regarded as being rela-
tively non-toxic [1,2]. Initially this opinion seemedtobe supportedby the facts that
it was used transiently as an anaesthetic and had been used commercially in indus-
try for many years [3].
The directinformation onthetoxicity ofvinyl chloride to manwas obtainedfrom
experiments by research workers on themselves, from the evaluation of its suit-
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ability as ananaesthetic [4, 5], andfromstudyofthecasesofvinylchloridepoison-
ing contracted during industrial use [6, 7, 8, 9].
Sporadic studieswithvinylchloridepolymerizationworkersdemonstratedvary-
ing degrees of hepatic biochemical derangements, hematological abnonnalities,
and skinchanges [9]. Acute shortterm exposures ledtodisturbancesofthecentral
nervous system, cardiac arrythmias, severe irritationofthe mucosalmembrane of
the eyes and the respiratory tract, and in some cases-severe pulmonary edema
with obstruction of the liver and kidneys. Chronic inhalation trials in animals
clearlyshowedthatvinylchloridewastoxictotheliverandkidneysaswellasirrita-
ting to the mucosal membranes and the lungs. Microscopic examination ofliver
sections showed degeneration of the central lobules while the damage to the
kidneys chiefly involved the tubule and the interstitiallining somewhatlikethatof
carbon tetrachloride damage [10, 11, 12].
BACKGROUND
The literature, however, contained virtually no information on damage to man
after chronic exposure until Filatova et al. reported disturbances of the blood
vessels and nerves in individuals exposed with 20-300 ppm ofvinyl chloride on a
continuous basis [13]. Cordieret al. [14] andWilson et al. [15] were thefirstto re-
portthehithertounrecognizeddisordertermedoccupational acroosteolysis (AOL)
whichincludedthesymptomsoftendernessofthefingertips,gradualdestructionof
bony integrity ofthe fingers and a Raynaud's-like phenomena.
Studieswereinitiatedinanimalstoreproducetheacroosteolysis. In 1971,Violiet
al. [16]whileexposinganimalsto30,000ppmtoinduceacroosteolysis, accidentally
discovered cancer. Maltoni et al. [17] while studying various levels ofexposure
demonstratedthatangiosarcomaoccured at250ppm; theManufacturing Chemists
Association's studies [18] demonstrated theselivercancersevenat50ppm. Atthe
same time, Dr. John Creech, at the B.F. Goodrich Chemical Company Plant in
Louisville, Kentucky, discovered an hepatic angiosarcoma in one employee.
Creech,recallinganearlierhepaticangiosarcomaattheplant,reviewedthemedical
histories of previous employees. Four additional angiosarcomas were found,
further supporting the connection between vinyl chloride exposure and tumor
development. Measures to control the levels ofvinyl chloride exposure were then
instituted following federal regulation.
THE CHEMICAL
Vinyl chloride's chemical structure is a double-bonded, 2-carbon halogenated
hydrocarbon which has structural similarities to tri-chloroethylene, an inhalation
anaesthetic. As previously noted, vinyl chloride was once considered as an
anaestheticbutwasdiscardedbecauseitcausedmyocardialirritability. Someofits
importantphysicalproperties include alowboilingpoint, ahigh specificgravity, a
low solubility in water, and a half-life in air which ranges from 3-20 hours.
Knowledge ofthesephysicalproperties maybe importantindetermining howthis
agent produces a cumulative effect in the environment which ultimately leads to
cancer formation.
Vinylchloride is bothtoxic andcarcinogenic, as recognizedbythe wide variety
of associated disorders which have been found among vinyl chloride polymeri-
zation workers and vinyl chloride-exposed animals. A yetincomplete listofthese
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TABLE I
Occupational Vinyl Chloride
Exposure Associated Disorders
1. Thrombocytopenia
2. Reticulocytosis
3. Splenomegaly
4. Hepatic fibrosis
5. Scleroderma-like skin changes
6. Acro-osteolysis
7. Raynaud's phenomenon
8. Leukopenia
9. Hepatomegaly
10. Pulmonary functional impairment
11. Angiosarcoma
12. Cardiac arrhythmia
13. Nephroblastomas*
14. Zymbal gland carcinomas*
15. Large cell lung cancer
16. Brain cancer
*In rats only
associated disorders is shown in Table 1. Animal and epidemiological studies
indicatetheprobabilitythatcancerinductionatothersitesisalsodirectlyattributed
to prolonged and excessive vinyl chloride exposure [19].
In order todevelop effective methods ofprevention, accurate knowledge ofthe
pathogenesis of this environmental chemical in ultimately producing its most
destructive effect-cancer-is needed.
EXPERIMENTAL ANIMAL STUDIES-TUMOR FORMATION
The carcinogenicity of vinyl chloride has been demonstrated in a variety of
animals as well as in humans at exposure levels that varyfrom50-30,000ppm. As
illustrated in Table 2, avariety oftumor types have been found in rats, mice, and
hamsters. Anextensive listofbenigntumorshave alsobeenreportedinmice, rats,
and hamsters exposed to vinyl chloride. Maltoni's group has now demonstrated
primary liver cell cancers in exposed newborn rats.
Directhepatocellularinjury aswellaspulmonary,mucosalandskininjurieshave
been shownindirectly exposedanimals. Pretreatmentwithmanyagents increases
thetoxicityofvinylchloride; theyincludephenobarbital, ethanol,polychlorinated
biphenylsandpesticides suchashexachlorobenzene [20].Thisrelationshiptovinyl
chloride's ability to induce cancer is under study, particularly in view of the
industrial environment which allows exposure to many chemicals to occur con-
currently.
HUMAN STUDIES
Epidemiological studies in the human strongly suggestthat exposure beyond 10
years is associated with increased cancer mortality, mainly digestive system
cancers, primarily hepatic [21, 22]. There also appears to be ahigherincidence of
large cell carcinomas ofthe lung, brain glioblastomamultiforms, and lymphomas
[23, 24], although there is somedisagreement as totheinterpretationofthisaspect
ofthe epidemiological data.
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TABLE 2
Carcinogenicity of Vinyl Chloride
(Exposure: 50-10,000 ppm)
TumorType Species
1. Liver-angiosarcoma Adulthumans, rats, miceandhamsters
2. Liver-hepatocellular carcinoma Newborn rats
3. Lung-adenocarcinoma Ratsandmice
4. Lung-largecellcarcinoma Humans*
5. Mammaryadenocarcinoma Mice
6. Zymbalglandtumors Rats
7. Nephroblastoma Rats
8. Osteochondromas Rats
9. Skin epitheliomas Hamsters
10. Melanomas Hamsters
11. Glioblastoma multiforme Humans*
12. Lymphoma Humans*
*Strongly suggested epidemiologically
The multisystem involvement ofthis carcinogenic and toxic chemical is further
illustrated in man. Early physical findings ofvinyl chloride-injury include hepato-
megaly, portal hypertension, possible mild systemic pulmonary hypertension,
bilateral midzonal pleural thickening of the lung, and splenomegaly with and
withoutincreasedportalpressure [25]. Theseanatomicalandphysiologicalfindings
most frequently occur in the absence of the traditional clinical biochemical
derangement ofthe liver. Screening studies ofvinyl chloride workers during the
past two and a half years have clearly illustrated the irregular and often delayed
appearanceofabnormalitiesinaspartateandalanineaminotransferases (SGOTand
SGP1T), alkaline phosphatase as well as other hepatocellular enzymes. Gamma
glutamic transpeptidase (GGTP), believed to be a more sensitive indicator of
hepatocellularinjury, hasproventohavetoohighafalse-positiveratetowarrantits
useinthe screensforhepatocellularinjury. Sorbitoldehydrogenase(SDH) studies
indicate that this enzyme, which is liver tissue specific, is too insensitive for
primary screening but is useful for confirmatory testing.
Anionic dyeclearance studies(IndocyanineGreen, ICG)havedemonstratedthe
highest specificity and sensitivity of all the primary screening procedures tested
whenperformed atthe 5 mg/kgdose level. Atthe traditional0.5mg/kglevel, ithas
the same effectiveness as the aminotransferases and alkaline phosphatase com-
bined. The frequency ofabnormal ICG dye clearances increases with prolonged
exposure to vinyl chloride as illustrated in Fig. 1 and correlates well with the
cumulative exposure to vinyl chloride as well as the histological evidence of
hepatocellular injury. These functional studies for detecting hepatocellular injury
do not, however, identify the cause.
Clinicalstudieshaveillustratedtheusefulnessofradioisotopicliver-spleenscans
as a primary screening procedure for anatomical lesions ofthe liver and spleen.
Thisprocedurehasproventobethesinglemostreliablemethodoftumordetection.
Sixteen ofthe 19individuals withanatomicallesions weredetectedbyliver-spleen
scan. In contrast, only 32 of950 normal individuals had scan abnormalities which
furtherdiagnostic studiesprovedincorrect. This methodprovidesan84% sensitiv-
ity and 97% specificity, with only a 3% false-positive rate.
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Diagnostic angiographic studies of these radioisotopic abnormalities in 80
individuals have demonstrated 3 major lesions. The first is peliosis hepatis,
illustrated in Fig. 2. These lesions are usually numerous involving the entire
liver, and have a diffuse stain throughout the nodules which persists into the late
venous phase without central hypovascularity [26].
A second, similar lesion has been discovered in individuals with splenomegaly,
and named lienal peliosis (Fig. 3). These splenic lesions demonstrate a shortened
celiac artery to portal vein circulation time, normal portal vein diameters, and
increased spleen size. This hasbeenfoundonlyinindividuals withlong-termvinyl
chloride exposure.
The final lesion is that ofangiosarcoma (Fig. 4). This tumor has characteristic
angiographic features of central hypovascularity, midarterial puddling, and a
prolonged peripheral tumor stain which continues up to 30-36 seconds after
injection. These characteristic findings have allowed differentiation from other
primary hepatocellular cancers, benign tumors and benign vascular lesions [26].
Theseangiographic lesions havebeenpathologicallyconfirmedwiththe additional
histological finding including peliosis hepatis, sinusoidal dilatation, and activated
sinusoidalcellswithincreaseddeposits ofcollageninthesinusoidalspaceofDisse.
Exploratory wedge biopsies have inaddition demonstrated increased subcapsular
fibrosis with subcapsular bile duct proliferation plus the often described portal
fibrosis [27].
VINYL CHLORIDE METABOLISM AND CARCINOGENESIS
Present biochemical knowledge indicates that vinyl chloride is most likely
metabolizedbythe liverinathree stepprocess [28]. Atconcentrations lessthan 50
ppm, vinyl chloride is metabolized by the alcoholic dehydrogenase system into
chloroacetaldehyde and monochloroacetic acid.
Cl-CH=CH2--Cl-CH2-CH2-OH alcohol 3Cl-CH2-CHO-oClCH2-COOH
dehydrogenase
Analternativepathwaywhichappears tobecomeoperative at220ppmisoxidation
by the peroxidase-catalase system.
Cl-CH2-CH2-OH H202 -CICH2-CH200H- -CICH2-CHO
catalase
LII 0.5mg/kg 5.0 mg/kg
TOTAL No. 5/5 13/ 15/ /8
100
80
460
FIG. 1. Frequency of abnormal 20
indocyanine green dye clearance
amongvinyl chloride workers utili- 0 1- 400 401 -800 801 -1200
zingO.5mg/kgand5.Omg/kgdoses. TOTAL VC EXPOSURE INDEX
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FIG. 2. Hepaticarteriogram: Ve-
nous phase. Changes of peliosis
hepatis are present throughout the
left lobe. The multiple nodular
stains represent peliosis hepatis
lesions (arrows) ranging from 2-3
mm to 2 cm in size.
FIG. 3. Splenicarteriogram: Ve-
nousphase(15 seconds). There are
3-4 circular and oval stains (ar-
rows) in the superior and inferior-
lateral portions ofthe spleen. Nor-
mal pancreatic stain occurs just
above the splenic vein.
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FIG. 4. Hepatic arteriogram:
Venous phase. At approximately
14-15 seconds the peripheral stain
is identified (arrows). lasting
throughtheentirephase. Scattered
areas ofpuddling are also present
in and around the area of central
hypovascularity.
Inthis casechloroacetaldehyde isagainformed. Athigherlevelsoxidationappears
to be by the mixed function oxidase system, forming chloroethylene oxide which
spontaneously rearranges to form chloroacetaldehyde which then can be further
oxidized to form monochloroacetic acid.
Cl-CH=CH2 oxidase - CL-CH CH2- 1 -CCI-CH2-CHO CICH2-COOH
As illustrated in Table 3, vinyl chloride oxidation intermediates chloroethanol
and chloroacetaldehyde, at low doses, are most likely detoxified via the glutathi-
one-cysteine conjugation system. This system, however, is saturable andathigher
levels vinyl chloride is excreted via the lungs [28]. It appears that at higher vinyl
chloride levels increased amounts of chloroethanol and chloroacetaldehyde are
further oxidized to chloroacetic acidwhich is excreted in the urine. This is further
supportedbytheabsenceofchloroaceticacidinurinesofratsexposedtolow,short
term levels ofvinyl chloride butfound inurine ofratsexposed to5,000ppmforan
extendedtimeandreportedinworkersexposedtolevelsgreaterthan250ppmfora
prolonged time [29, 30].
Elmore et al., utilizing a modified Ames system and pure synthesized vinyl
chloride intermediates, has demonstrated that vinyl chloride, chloroethanol, and
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TABLE 3
Proposed Metabolic Fate of Vinyl Chloride
Cl CH = CH2
(VC) Detoxification with glutathione
Liver MFO
I> ^ Cl CH2 CH2 OH
Cl CH-CH2 (Chloroethanol)
OI +GSH
0
(Clooxian)Cl CH2 CHO -*G S CH2 CHO -*GS CH2 COOH (Chlorooxirane) (Chloroacetaldehyde)
Thiodiglycolic
acid
Cl CH2 COOH
(Chloroacetic acid)
chloroacetic acid are not mutagenic in bacteriological systems [31]. This may
indicate that the vinyl chloride monomer is neither hepatotoxic nor carcinogenic
until it has been metabolized to its intermediate forms by the liver and/or other
tissues.
Alternatively, chloroethanol-the most transportable of the vinyl chloride
metabolites-may be transferred ordiffused to adjacent cells, such as the sinusoi-
dalliningcells,whereitcouldbeconverted tochloroacetaldehyde butlesslikelyto
be detoxified or further oxidized. Since vinyl chloride appears to bind the serum
albumin, it may, itselfbe transported to and oxidized by extra-hepatic cells which
are unable tofully oxidize orcompletely detoxify its metabolites, and thereby lead
to molecular DNA injury and cancer formation at distant tissue sites.
These quandaries led to further study of the hepatochemical changes in rats
undergoing progressively increased exposure to vinyl chloride. Subcellular en-
zymes and metabolites were studied in animals exposed to from 10-20,000 ppm
vinyl chloride, rangingfrom 14-137 hours. Microsomal enzymes, including P450,
NADPH cytochrome c reductase, and mixed function oxidases were studied.
Determinations of cytochrome c oxidase as the mitochondrial, tritiated-leucine
incorporation as the protein synthesis and glucose-6-phosphatase as the carbo-
hydrate metabolism markers were also done. Glutathione and glutathione reduc-
tase as oxidative and detoxification markers were determined in addition to the
conventionalclinicalbiochemical studieswhichincludedtheaspartate(SGOT)and
alanine aminotransferase (SGPT), alkaline phosphatase, bilirubin, lactic acid
dehydrogenase (LDH), total protein, albumin, cholesterol, and triglycerides.
During the entire 137 hours ofexposure there were nosignificant changes inthe
mitochondrial andthe microsomal enzymes, the tritiated-leucineincorporation, or
in the glutathione content. There was however, after 71 hours, a rise in the gluta-
thione reductase and a concomitant fall in glucose-6phosphate. This occurred
without any histologically discernible changes in the hepatocytes by light micro-
scopy norany significantchanges inthe conventional clinicalbiochemical studies.
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The discovery ofadecreased glucose-6-phosphatase after "simulated" chronic
exposure led to the study of enzymes in the pentose phosphate shunt pathway.
Weber and Lea [32] had found similar changes for primary hepatocellular neo-
plasms, demonstrating that in a rapidly developing primary hepatocellular tumor,
there is decreasedgluconeogenesis withareduction intheglucose-6-phosphatase,
followed by an increase inglucose--phosphate dehydrogenase and transaldolase.
These biochemical changes were alsofollowedby anincrease inpurinebiosynthe-
sis (increased phosphoribosylpyrophosphate aminotransferase (PRP.P) and in-
creases in the production of ATP and GTP leading to increased nucleic acid
synthesis.
Vinyl chloride-exposed animals showed no significantchanges in theglucose-6
phosphatase dehydrogenase activity during the initial 84 hours of exposure.
However, after 103 hours, there was significant increase inglucose-6phosphatase
dehydrogenase. Studies ofPRPP, at least up to 137 hours, have as yet shown no
significantchanges. Studies are nowunderwayusinganimalsexposed to 130to250
hours to determine ifthe biochemistry in vinyl chloride injury is similar to that in
primary hepatocellular tumors.
This, however, doesnotexplainwhythehepatocyte,whichistheprimarycellfor
oxidizinganddetoxifying vinylchloride, is nottheprimary targetforcancertrans-
formation. Howdothehepatocyticbiochemicalchanges, seenintheearlyphaseof
highvinylchlorideexposure, relatetothelatermorphologicalchangesthatoccurin
the adjacent sinusoidal cells?
MORPHOLOGICAL FINDINGS
Electron microscopic examination ofliver sections ofmice exposed from 1 to 6
months to 2,50046,000 ppm vinyl chloride, for 5 hours/day, 5 days/week-alevel
knowntoinduceangiosarcoma[33}-havedemonstratedhepatocellularchangesas
early as one month. These changes included hypertrophy of the smooth endo-
plasmic reticulum (believed to reflect vinyl chloride metabolism) and, plasma
membrane lossofmicrovilli withinvaginations-possibly reflecting the movement
of injurious metabolites across the membrane and out of the cell, allowing the
metabolites to be picked up by the sinusoidal cells [34].
The sinusoidalcellreactionsweremulticellular. Increasingnumbers andsizesof
lipocytes were seen with little fibrosis. Macrophages were seenfilled with phago-
somes, sometimes containing longneedle-like crystals. Althoughthere were many
mononuclear cells present, the main abnormalities were seen in the endothelial
liningcells. Intheearlystagestheyarelargerandthicker-possiblyswollen. Later,
they became bulky and in places, multi-layered containing increased organelles,
especially mitochondria andendoplasmic reticulum. Laterdisruptions in the sinu-
soidal walls seen were consistent with beginning peliosis hepatis. The lining cells,
probably the precursors ofangiosarcoma, often resembled fibroblasts. However,
their endoplasmic reticulum did not contain any collagen components. These
observationsbySchaffneretal. [34]givesupporttothesuggestionthatmetabolites
of vinyl chloride produced in the hepatocytes may be transported through the
plasma membrane and enter sinusoidal lining cells, eventually leading to angio-
sarcoma. Attempts at screening for vinyl chloride hepatic injury might be better
aimed at the endothelial cells and thehepatic sinusoidal circulation ratherthanthe
hepatocytes.
Our work in humans has identified similar findings. One major difference at
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present is an increased collagen deposition, characteristic ofhuman vinyl chloride
injury andlikely species specific. Light microscopic studies utilizing special stains
on hepatic tissue from individuals with extensive exposure to vinyl chloride but
without clinical biochemical hepatic abnormalities have shown distinctive mid-
zonal increased deposition of collagen in the space of Disse [35]. Routine light
microscopic studies using hematoxylin and eosin failed to easily demonstrate this
midzonal increased collagen. The increased deposition along the hepatic cell
surface is associated with larger sinusoidal space and activation ofthe sinusoidal
lining cells illustrated by increased nuclear size and cytoplasmic content. The in-
creased collagendeposition, whenstudiedelectronmicroscopically, demonstrates
compression ofthehepatocytesbythe collagenbundleswhichinitiallygivetheap-
pearance of intra-hepatocellular collagen bundles as illustrated in Fig. 5. The
strands ofcollagen appear to compress the hepatocytes causing cords ofhepato-
cytes to be broken and to coalesce with adjoining sinusoids eventually leading to
peliosis hepatis-like lesions.
Theseobservationsledus tothestudyoftheproteroglycanroleincollagenform-
ationinvinylchloride-exposedworkers. Ithadbeensuggestedintheliteraturethat
glycosaminoglycans inbloodand/orurine mightbeusefulasmeansofearlycancer
detection since a number of studies had demonstrated the production ofsulfated
glycosaminoglycans with malignant states. Pathologists have often used this
feature as adiagnostic aid in characterizing malignant vasculartumors ofthe skin
F ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~A
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FIG. 5. Electron microscopy _ *
showing collagen (CB) bundles
(arrows) invaginating into the hep-
atocyte, giving the appearance of I
inter-hepatocytic collagen. N =
nucleus; 5 sinusoidal space: ...
IM -invagination into the cell " ,
membrane (small arrows).
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[36]. Others have noted a strong positive Alcian blue glycosaminoglycan staining
reaction in human angiosarcoma tissue [37]. This suggested that quantitative and
qualitative determinations of glycosaminoglycan production in individuals with
neoplasm, eitherby serumorurine,mightbeusedtoidentifythoseathighriskoras
an early indicator of neoplastic formation. The feasibility ofglycosaminoglycan
"spot test" forvinyl chloride production workers madethis an attractivepossibil-
ity for mass screening.
Urinaryglycosaminoglycans, measuredas uronicacid, were studiedinindividu-
als with alcoholic cirrhosis, viral hepatitis, secondary liver metastasis, hepatic
angiosarcoma and normal controls.
Thepercentage oftotalglycosaminoglycans thatwasdialyzable andthepercent-
ageofunfractionatedtotalthatappearedinthehyaluronicacid,chondroitinsulfate,
or in the heparin fractions was similar for all groups. However the distribution of
positive fractions varied with the different groups studied.
Seven of the nine vinyl chloride-exposed individuals, other than those with
angiosarcoma, had glycosaminoglycan positive chondroitin sulfate fractions with
negative hyaluronic acid and heparin fractions whereas this occurred in only 3 of
the 32 urines from other hepatic diseases [38].
In addition, study ofthe total tissue glycosaminoglycan levels in angiosarcoma
tumors and fibrotic tissue adjacent to the tumor demonstrated that tumor tissue
itselfhadhigherlevels ofhyaluronic acid andheparin fractions ascompared tothe
non-tumoradjacenttissuewhich hadhigherlevels ofchondroitin sulfate fractions.
A similarrelationship wasfound incirrhotic livertissue and normal controls. This
data conforms to reports by others that both hepatic connective tissue disorder
[39,40,41,42,43] andhepatic cancer [44] result in increased hepatic glycosamino-
glycan levels. It may be significant that the angiosarcoma patient has half the
urinary glycosaminoglycan excretion of patients with liver metastasis and that
analysis ofangiosarcoma tumortissueexhibits halftheglycosaminoglycan content
reported by Kojima et al. [44] forhepatocellular carcinoma. The increases in liver
and urinaryglycosaminoglycans may well reflect the importance ofthese substan-
ces in the process of fibrogenesis and tumor growth. Although no significant
differences werefound intotalglycosaminoglycans ofvinylchloride-exposed indi-
viduals with associated liverinjury, there was a significant difference in the excre-
tion patterns of these individuals. Seventy-eight percent of them had positive
chondroitin sulfate fractions in contrast to only nine percent ofthe non-exposed
liver injury cases. Thus the change in the glycosaminoglycan excretion pattern in
individuals with pre-cancerous injuries may be of significant prognostic and
diagnostic importance [45].
The urinary glycosaminoglycan excretion patterns in an angiosarcoma patient 3
monthsto2weekspriortodeathdemonstratedanincrease intheurinarychondroi-
tin sulfate fraction with a change in its composition as the disease progressed.
Duringthistime, thechondroitinsulfatecompositionshowedacontinuous increase
in the ratio of the 1.25 M NaCl to the 1.5 M NaCl fractions. This was due to an
increase inthe 1.25 Meluate andadecrease inthe 1.5 Meluate fraction and was 2.3
timesgreaterthanthecontrols. Inthemostadvanced stageoftheangiosarcomathe
ratio increased to 13.7 times greater [46].
These very preliminary studies would suggest that alterations in the ratios of
these fractions' compositions may be useful in evaluating the severity and
subsequentprogressionofdisease. Earlylesions mayproduce smallchanges inthe
ratio which would become more pronounced as the disease worsened. The
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significant injury or continuing progression of disease despite changes in the
environment. Finally therapeutic measures forinterventionmightbe betterevalu-
ated for their effectiveness in arresting cancer development as reflected by the
glycosaminoglycan changes which in turn reflect changes in collagen formation.
SUMMARY AND HYPOTHESIS
Vinyl chloride appears to enter the body through the respiratory tract, the skin,
or by swallowing; it is absorbed and transported to the liver by the systemic and
portal circulatory systems. In the liver, the primary site of metabolism, it is
oxidized by various enzyme systems: alcohol dehydrogenase at lower exposure
levels; the peroxidase-catalase system at intermediate levels; and mixed function
oxidases at higher levels. At the higher levels, the mixed function oxidase system
transforms vinyl chloride to chlorooxiranes which are then spontaneously trans-
formed into choroethanol and chloroacetaldehyde.
These two intermediate metabolites, chloroethanol and chloroacetaldehyde, are
detoxified by conjugation with glutathione and cysteine-SH groups and are
excretedintheurine. At evenhigherdosesincreasing amountsofthechloroacetal-
dehyde are further oxidized to chloroacetic acid and excreted as an endproductin
the urine. However, when chloroacetaldehyde and/or the chlorooxiranes exceed
the detoxification threshold ofthe hepatocyte, this leads to hepatocellulartoxicity
and/orstimulationofthe sinusoidalcells. Thisacuteeventinturnactsasastimulat-
ing mechanism for increased collagen deposition in the space of Disse and
sinusoidal areasas shownbyelectronandlightmicroscopy studies. Theincreasein
the collagen depostion in sinusoidal spaces then leads to disruption ofhepatic cell
surfacefunction, disruption ofthe hepatic cords, coalitionofthe sinusoidal spaces
and eventual peliosis hepatis. These lesions alternately lead to sufficient vascular
dysfunction to add further to the biochemical manifestation of hepatic cellular
injury.
Since it is highly unlikely that the unstable chlorooxiranes are able to be trans-
ported to adjacent cells and that the chloroacetaldehyde would most likely be
conjugated or detoxified within the hepatocyte, an intermediate form, such as
chloroethanol, which is transportable from the hepatocyte, may then move on to
the adjacent sinusoidal lining cells, or possibly even further to other extrahepatic
tissue. At these extrahepatic sites, an intermediate, such as chloroethanol, may
then be converted to chloroacetaldehyde. The extrahepatic tissue sites are most
likely unable tofurther convert the chloroacetaldehyde to chloroacetic acid norto
detoxify it sufficiently, if at all, by their own detoxification systems. This would
allow a longer contact period with the cell's DNA. In addition many ofthe extra-
hepatic cells normally are regenerating at faster rates than hepatocytes, thus
increasing the possibility of DNA derangement and ultimate carcinogenesis.
Alternatively, vinyl chloride itself may be taken up by extrahepatic tissue,
oxidizedbutincompletely detoxified, allowingthecell itselftobecome susceptible
to direct DNA injury. In this or similar manner, chemical metabolites may induce
injury to the DNA in rapidly replicating cells at sites beyond the liver, thus
accounting for other cancers developing with vinyl chloride.
The recent work by Maltoni's group, showing that exposure ofnewborn rats to
the same dose of vinyl chloride as adult rats, results in primary hepatocellular
carcinoma(40-45%)ratherthaninangiosarcoma(8-12%o), lendsfurthersupport to
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the concept that the hepatocyte's ability to resist cancer transformation is
dependent upon its ability to detoxify the mutagenic/carcinogenic metabolite of
vinyl chloride.
This review of our present knowledge of vinyl chloride injury and cancer
formation in man is, at best, a very rough hypothetical outline. With continued
investigationand study itwill allowus tomoreaccurately andcompletelyfillinthe
missingpiecesofthisfascinatingpuzzle,thusleadingustoabetterunderstandingof
the pathogenesis ofchemically induced cancer in the biologically complex human
system.
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